Pharmaceutical compositions for bioactive peptide agents
WO2005001075A1
Rdp58 compositions and methods for modulating the activity of osteoclasts and osteoblasts
WO2005009457A1
Rdp58 compositions and methods for inhibiting vascularization of cell populations
CN1735425A
Cytomodulating peptides for treating interstitial cystitis
BR0316290A
Method of Treating Interstitial Cystitis
AU2003286611A1
Cytomodulating peptides and methods for treating neurological disorders
AU2003263043A8
Methods and compostions for immune tolerance
BR0307979A
Pharmaceutical method and preparation for reducing cytoablatic therapy-induced gastrointestinal toxicities, and method for improving cytoablative cancer therapy
WO03061602A2
Combination therapy for treatment of hiv infection
IL158182D0
Carbon monoxide generating compounds for treatment of vacular, inflammatory and immune disorders
AU1550202A
Graft survival prolongation with porphyrins
US7528240B2
Method for producing human anti-thymocyte immunoglobulins
AU1349300A
Cytomodulating conjugates of members of specific binding pairs
CA2355066A1
Extending graft survival by heme oxygenase-i expression induced immunomodulation
AU6303399A
Oral cyclosporin formulations
WO0013028A1
Method for identifying shared antigenic epitopes
AU3096099A
Immunomodulatory fragments of polyclonal antilymphocyte globulins (algs) and uses thereof
AU1124799A
System and method for managing administration of medicine
CZ233799A3
Peroral pharmaceutical preparations of cyclosporin
CA2286478A1
Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
